Making Science Group SA
MAD:MAKS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Making Science Group SA
MAD:MAKS
|
ES |
|
Brainsway Ltd
NASDAQ:BWAY
|
IL |
|
ESR-REIT
OTC:CGIUF
|
SG |
|
C
|
CNH Industrial NV
F:37C
|
UK |
|
C
|
Camsing Healthcare Ltd
SGX:BAC
|
SG |
|
Velocity Minerals Ltd
XTSX:VLC
|
CA |
|
Purple Innovation Inc
NASDAQ:PRPL
|
US |
|
Carisma Therapeutics Inc
OTC:CARM
|
US |
|
R
|
Realty Income Corp
XMUN:RY6
|
US |
|
C
|
China Merchants Port Holdings Co Ltd
F:CPM
|
HK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MAKS's stock price target?
Not Available
MAKS does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Making Science Group SA?
Projected CAGR
22%
Over the last 1 year, the compound annual growth rate for Revenue has been 27%. The projected CAGR for the next 2 years is 22%.
What is the Gross Profit forecast for Making Science Group SA?
Projected CAGR
30%
Over the last 1 year, the compound annual growth rate for Gross Profit has been -13%. The projected CAGR for the next 2 years is 30%.
What is the Operating Income forecast for Making Science Group SA?
Projected CAGR
532%
Over the last 1 year, the compound annual growth rate for Operating Income has been -96%. The projected CAGR for the next 2 years is 532%.
What is the Net Income forecast for Making Science Group SA?
Projected CAGR
-69%
The compound annual growth rate for Net Income over the next 2 years is -69%.